Supplementation with Boswellia serrata extract versus placebo for knee osteoarthritis treatment
A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the kneePhytother Res. 2019 May;33(5):1457-1468. doi: 10.1002/ptr.6338
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
48 patients with knee osteoarthritis were randomized to daily oral supplementation with either Boswellia serrata extract or placebo. Patients were followed over 4 months of treatment for outcome related to pain and function. After 4 months, results demonstrated significantly greater improvement in the BSE group for the Western Ontario and McMaster Universities Osteoarthritis Index, visual analog p...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE